Nuvo Pharmaceuticals Growth, Revenue, Number of Employees and Funding

Overview

Location:
Toronto, ON Canada
Total Funding:N/A
Industry:Pharma
Founded:1983
Lead Investor(s):N/A
Press

Estimated Revenue & Financials

  • Nuvo Pharmaceuticals's estimated revenue is currently $10.9M per year.
  • Nuvo Pharmaceuticals received $6.0M in venture funding in August 2017.
  • Nuvo Pharmaceuticals's estimated revenue per employee is $187138

Employee Data

  • Nuvo Pharmaceuticals has 58 Employees.
  • Nuvo Pharmaceuticals grew their employee count by 21% last year.
  • Nuvo Pharmaceuticals currently has 1 job openings.

Executive Contacts

NameTitle
Sandee DelaDirector of IT
Chantal PareDirector Quality Assurance
Wade HullVice President, R&D / CMC
Jesse LedgerPresident/CEO
Cally LunettaVP Manufacturing
Tina LoucaidesVP Secretary & General Counsel
Mary-Jane BurkettVP/CFO
Nicole RusawInterim Chief Financial Officer
Bernard ChiassonChief Scientific Officer

What Is Nuvo Pharmaceuticals?

Nuvo (TSX:NRI) is a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities. Nuvo has three commercial products that are available in a number of countries; Pennsaid 2%, Pennsaid and the heated lidocaine/tetracaine patch. Pennsaid 2% is sold in the U.S. by Horizon Pharma plc (NASDAQ:HZNP) and is available for partnering in certain other territories around the world. Nuvo manufactures Pennsaid for the global market and Pennsaid 2% for the U.S. market at its FDA licensed GMP facility in Varennes, Québec.

keywords:N/A

58

Number of Employees

$10.9M

Revenue (est)

1

Current Jobs

21%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Turnkey Modular...
$7M3728%N/A
PharmEng Techno...
$31.6M16813%N/A
Allphase Clinic...
$7.4M4014%N/A
Janssen
$1440.2M76677%N/A
Fresenius Kabi ...
$21.7M11622%N/A
Everest Clinica...
$33M17517%N/A
Robarts Clinica...
$48.2M25714%N/A
Novapharm Limit...
$18.7M1003%N/A
Dalton Pharma S...
$25.1M1345%N/A
Acerus Pharma
$6.6M353%N/A

Nuvo Pharmaceuticals News

09/03/2019 - Nuvo Pharmaceuticals™ to Present at HC Wainwright Global Investment Conference

MISSISSAUGA, ON, Sept. 4, 2019 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI;OTCQX:NRIFF), a Canadian ...

09/08/2019 - Nuvo Pharmaceuticals™ Announces 2019 Second Quarter Results

Nuvo to Host Conference Call/Audio Webcast August 14th at 8:30 a.m. ET - ... 14, 2019 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the ...

09/03/2019 - Edited Transcript of NRI.TO earnings conference call or presentation 14-Aug-19 12:30pm GMT

Q2 2019 Nuvo Pharmaceuticals Inc Earnings Call. MISSISSAUGA Sep 7, 2019 (Thomson StreetEvents) -- Edited Transcript of Nuvo ...

Nuvo Pharmaceuticals Funding

DateAmountRoundLead InvestorsReference
2017-08-25$6.0MUndisclosedRoyal Bank of Canada (RBC)Article

Nuvo Pharmaceuticals Executive Hires

DateNameTitleReference
2017-11-23Jesse LedgerPresident/CEOArticle
2017-11-23John LondonChairmanArticle